About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting 12-02-2021 at 8:01 AM EST Adaptive Biotechnologies Receives Updated Medicare Coverage for its Minimal Residual Disease (MRD) Assay, clonoSEQ® for Blood Cancer Patients 11-11-2021 at 5:52 PM EST Adaptive Biotechnologies Reports Third Quarter 2021 Financial Results 11-03-2021 at 4:05 PM EDT VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Adaptive Biotechnologies Third Quarter Financial Results Nov 3, 2021 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q3 2021 Earnings Presentation 1.3 MB Morgan Stanley Global Healthcare Conference Sep 14, 2021 at 8:00 AM PDT Listen to webcast Adaptive Biotechnologies Second Quarter Financial Results Aug 4, 2021 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Second Quarter Earnings Presentation 1.4 MB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Dec 5, 2021 6:02 AM ESTData Provided by Refinitiv. Minimum 15 minutes delayed.
